» Articles » PMID: 36149817

Bone Health in Adults With Prader-Willi Syndrome: Clinical Recommendations Based on a Multicenter Cohort Study

Abstract

Context: Prader-Willi syndrome (PWS) is a rare complex genetic syndrome, characterized by delayed psychomotor development, hypotonia, and hyperphagia. Hormone deficiencies such as hypogonadism, hypothyroidism, and growth hormone deficiency are common. The combination of hypotonia, low physical activity, and hypogonadism might lead to a decrease in bone mass and increase in fracture risk. Moreover, one would expect an increased risk of scoliosis due to hypotonia and low physical activity.

Objective: To study the prevalence and risk factors for skeletal problems (reduced bone mineral density, fractures, and scoliosis) in adults with PWS.

Methods: We retrospectively collected patient characteristics, medical history, medication, biochemical measurements, dual-energy X-ray absorptiometry scans, and spinal X-rays and reviewed the current literature.

Results: We included 354 adults with PWS (median age 31 years; 43% males), of whom 51 (14%) had osteoporosis (T-score below -2.5) and 143 (54%) had osteopenia (T-score -1 to -2.5). The most prevalent modifiable risk factors for osteoporosis were hypogonadism, insufficient dairy intake, sedentary lifestyle, and corticosteroid use. Male sex was associated with osteoporosis (P = .005). Growth hormone treatment was not associated with osteoporosis. A history of vertebral fractures was present in 10 (3%) and nonvertebral fractures in 59 (17%). Scoliosis was present in 263 (80%), but no modifiable risk factors were identified.

Conclusion: Besides scoliosis, osteoporosis is common in adults with PWS. Based on the literature and the risk factors for osteoporosis found in our cohort, we provide practical clinical recommendations to avoid skeletal complications in these vulnerable patients.

Citing Articles

The "Burden" of Childhood Obesity on Bone Health: A Look at Prevention and Treatment.

Farella I, Chiarito M, Vitale R, DAmato G, Faienza M Nutrients. 2025; 17(3).

PMID: 39940349 PMC: 11821239. DOI: 10.3390/nu17030491.


Puberty in girls with Prader-Willi syndrome: cohort evaluation and clinical recommendations in a Latin American tertiary center.

Passone C, Aragao L, Franco R, Leite J, Gonzalez M, Schil P Front Endocrinol (Lausanne). 2024; 15:1403470.

PMID: 38966214 PMC: 11222560. DOI: 10.3389/fendo.2024.1403470.


Prader-Willi syndrome: guidance for children and transition into adulthood.

Shaikh M, Barrett T, Bridges N, Chung R, Gevers E, Goldstone A Endocr Connect. 2024; 13(8).

PMID: 38838713 PMC: 11301552. DOI: 10.1530/EC-24-0091.


Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation.

Madeo S, Zagaroli L, Vandelli S, Calcaterra V, Crino A, de Sanctis L Front Endocrinol (Lausanne). 2024; 15:1382583.

PMID: 38737552 PMC: 11082343. DOI: 10.3389/fendo.2024.1382583.


Differences in spinal postures and mobility among adults with Prader-Willi syndrome, essential obesity, and normal-weight individuals.

Bayartai M, Luomajoki H, Tringali G, De Micheli R, Grugni G, Sartorio A Front Endocrinol (Lausanne). 2023; 14:1235030.

PMID: 37800136 PMC: 10548364. DOI: 10.3389/fendo.2023.1235030.


References
1.
Hui S, Gao S, Zhou X, JOHNSTON Jr C, Lu Y, Gluer C . Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments. J Bone Miner Res. 1997; 12(9):1463-70. DOI: 10.1359/jbmr.1997.12.9.1463. View

2.
Crews M, Howes O . Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications. Hum Psychopharmacol. 2012; 27(1):15-23. PMC: 3731625. DOI: 10.1002/hup.1265. View

3.
Felson D, Zhang Y, Hannan M, Anderson J . Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res. 1993; 8(5):567-73. DOI: 10.1002/jbmr.5650080507. View

4.
Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D . Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet. 2002; 359(9301):135-6. DOI: 10.1016/S0140-6736(02)07340-3. View

5.
Baraghithy S, Smoum R, Drori A, Hadar R, Gammal A, Hirsch S . Magel2 Modulates Bone Remodeling and Mass in Prader-Willi Syndrome by Affecting Oleoyl Serine Levels and Activity. J Bone Miner Res. 2018; 34(1):93-105. DOI: 10.1002/jbmr.3591. View